Grimes & Company Inc. Acquires 189 Shares of Cigna Group $CI

Grimes & Company Inc. grew its position in Cigna Group (NYSE:CI) by 15.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,442 shares of the health services provider’s stock after purchasing an additional 189 shares during the quarter. Grimes & Company Inc.’s holdings in Cigna Group were worth $477,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. Family Legacy Inc. raised its position in shares of Cigna Group by 0.5% in the first quarter. Family Legacy Inc. now owns 6,497 shares of the health services provider’s stock valued at $2,138,000 after purchasing an additional 31 shares during the period. Impact Investors Inc raised its position in shares of Cigna Group by 1.6% in the first quarter. Impact Investors Inc now owns 1,975 shares of the health services provider’s stock valued at $650,000 after purchasing an additional 31 shares during the period. Mission Wealth Management LP raised its position in shares of Cigna Group by 1.5% in the first quarter. Mission Wealth Management LP now owns 2,101 shares of the health services provider’s stock valued at $691,000 after purchasing an additional 32 shares during the period. Westend Capital Management LLC raised its position in shares of Cigna Group by 8.1% in the first quarter. Westend Capital Management LLC now owns 427 shares of the health services provider’s stock valued at $140,000 after purchasing an additional 32 shares during the period. Finally, Financial Network Wealth Advisors LLC raised its position in shares of Cigna Group by 26.8% in the first quarter. Financial Network Wealth Advisors LLC now owns 161 shares of the health services provider’s stock valued at $53,000 after purchasing an additional 34 shares during the period. Institutional investors own 86.99% of the company’s stock.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the transaction, the insider owned 25,648 shares in the company, valued at $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the sale, the insider owned 51,182 shares in the company, valued at $15,354,600. This represents a 9.49% decrease in their position. The disclosure for this sale can be found here. 0.70% of the stock is owned by company insiders.

Cigna Group Trading Up 1.4%

Shares of CI stock opened at $307.21 on Wednesday. The firm has a fifty day moving average of $292.94 and a 200-day moving average of $309.54. The stock has a market cap of $82.00 billion, a price-to-earnings ratio of 16.77, a P/E/G ratio of 0.89 and a beta of 0.45. Cigna Group has a 52-week low of $256.89 and a 52-week high of $358.88. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, beating the consensus estimate of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. During the same period in the previous year, the business earned $6.72 EPS. The firm’s revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities research analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were paid a dividend of $1.51 per share. The ex-dividend date was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a yield of 2.0%. Cigna Group’s dividend payout ratio (DPR) is currently 32.97%.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on CI. Wells Fargo & Company lifted their price target on shares of Cigna Group from $340.00 to $354.00 and gave the company an “equal weight” rating in a research report on Tuesday. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on shares of Cigna Group and gave the stock a “buy” rating in a research note on Tuesday, August 5th. TD Cowen upgraded shares of Cigna Group to a “strong-buy” rating in a research note on Monday, June 23rd. Barclays raised their price objective on shares of Cigna Group from $354.00 to $383.00 and gave the stock an “overweight” rating in a research note on Thursday, September 4th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Cigna Group in a research note on Saturday, September 27th. Two research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, Cigna Group has an average rating of “Moderate Buy” and an average price target of $372.69.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.